Source : http://www.rns-pdf.londonstockexchange.com/rns/3844W_-2010-11-17.pdf
Investment Portfolio as at 30th September 2010 | ||||
Value of | ||||
investment | % of | |||
Investment holdings | Country | £ million | NAV | |
Quoted equities | ||||
BR Properties | Brazil | Brazilian real estate | 21.1 | 1.2% |
Watson Pharmaceuticals | United States | Pharmaceuticals | 18.7 | 1.0% |
Paypoint | United Kingdom | Electronic payment systems | 17.3 | 0.9% |
RHJ International | Belgium | Investment company with Japanese focus | 17.1 | 0.9% |
Transocean | United States | Offshore drilling contractor | 12.7 | 0.7% |
Phoenix Group Holdings | United Kingdom | Life insurance and related products | 11.9 | 0.7% |
Roche Holdings | Switzerland | Pharmaceuticals | 10.2 | 0.6% |
Laboratory Corporation of America Holdings | United States | Clinical laboratories | 10.1 | 0.6% |
Vallar | United Kingdom | Mining investments | 9.0 | 0.5% |
Euler Hermes | France | Credit insurance | 6.4 | 0.4% |
Western Union | United States | Money transfer services | 5.8 | 0.3% |
Other quoted equities | 35.1 | 2.0% | ||
Total quoted equities | 175.4 | 9.8% | ||